Plain-English translation of NCT04209244 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether Eskimo-3 Pure Fish Oil, taken as a daily supplement, can help prevent high cholesterol and reduce serious side effects in children and young adults undergoing treatment for acute lymphoblastic leukemia (ALL). The medication contains omega-3 fatty acids that have been shown in other studies to lower cholesterol and triglycerides, which often become elevated during ALL treatment. Researchers believe the medication may help protect patients from complications like bone damage, blood clots, and other serious conditions that can develop during therapy.
While treatments for ALL have become much more effective—with over 90% of children now surviving—these powerful medicines can cause serious side effects that affect patients' quality of life and long-term health. This medication is being studied because it may be a simple, safe way to prevent some of these harmful side effects from developing in the first place.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would take either a daily fish oil supplement or a placebo (inactive oil) by mouth throughout your leukemia treatment. A research team will monitor your cholesterol levels and watch for side effects regularly as part of your normal cancer care. The study is designed to run alongside your regular treatment schedule, so participation would not require extra hospital visits beyond what you're already receiving.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Denmark